The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection
Open accessAbstract
West Nile virus (WNV) is a neurotropic flavivirus within the Japanese encephalitis antigenic complex that is responsible for causing West Nile encephalitis in humans. The surface of WNV virions is covered by a highly ordered icosahedral array of envelope proteins that is responsible for mediating attachment and fusion with target cells. These envelope proteins are also primary targets for the generation of neutralizing antibodies in vivo. In this study, we describe a novel approach for measuring antibody-mediated neutralization of WNV infection using virus-like particles that measure infection as a function of reporter gene expression. These reporter virus particles (RVPs) are produced by complementation of a sub-genomic replicon with WNV structural proteins provided in trans using conventional DNA expression vectors. The precision and accuracy of this approach stem from an ability to measure the outcome of the interaction between antibody and viral antigens under conditions that satisfy the assumptions of the law of mass action as applied to virus neutralization. In addition to its quantitative strengths, this approach allows the production of WNV RVPs bearing the prM-E proteins of different WNV strains and mutants, offering considerable flexibility for the study of the humoral immune response to WNV in vitro. WNV RVPs are capable of only a single round of infection, can be used under BSL-2 conditions, and offer a rapid and quantitative approach for detecting virus entry and its inhibition by neutralizing antibody.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanciotti, R. S., Roehrig, J. T., Deubel, V., Smith, J., Parker, M., Steele, K., Crise, B., Volpe, K. E., Crabtree, M. B., Scherret, J. H., et al. (1999) · Science · doi:10.1126/science.286.5448.2333 · Cited by 1,593
Cited by
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884
Self-citationGuidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
Roehrig, J. T., Hombach, J., & Barrett, A. D. T. (2008) · Viral Immunology · doi:10.1089/vim.2008.0007 · Cited by 450
Rapid development of a DNA vaccine for Zika virus
Dowd, K. A., Ko, S.-Y., Morabito, K. M., Yang, E. S., Pelc, R. S., DeMaso, C. R., Castilho, L. R., Abbink, P., Boyd, M., Nityanandam, R., et al. (2016) · Science · doi:10.1126/science.aai9137 · Cited by 396
Self-citationA CRISPR screen defines a signal peptide processing pathway required by flaviviruses
Zhang, R., Miner, J. J., Gorman, M. J., Rausch, K., Ramage, H., White, J. P., Zuiani, A., Zhang, P., Fernandez, E., Zhang, Q., et al. (2016) · Nature · doi:10.1038/nature18625 · Cited by 369
Self-citationJemielity, S., Wang, J. J., Chan, Y. K., Ahmed, A. A., Li, W., Monahan, S., Bu, X., Farzan, M., Freeman, G. J., Umetsu, D. T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003232 · Cited by 364
Self-citationWest Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection
Davis, C. W., Nguyen, H.-Y., Hanna, S. L., Sánchez, M. D., Doms, R. W., & Pierson, T. C. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1290-1301.2006 · Cited by 354
Self-citationRecurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Robbiani, D. F., Bozzacco, L., Keeffe, J. R., Khouri, R., Olsen, P. C., Gazumyan, A., Schaefer-Babajew, D., Avila-Rios, S., Nogueira, L., Patel, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.024 · Cited by 333
Macagno, A., Bernasconi, N. L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M. G., Gerna, G., Sallusto, F., & Lanzavecchia, A. (2010) · Journal of Virology · doi:10.1128/jvi.01809-09 · Cited by 326
Kramer, L. D., Li, J., & Shi, P.-Y. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70030-3 · Cited by 318
The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., & Diamond, M. S. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.03.002 · Cited by 308
Self-citationOliphant, T., Nybakken, G. E., Engle, M., Xu, Q., Nelson, C. A., Sukupolvi-Petty, S., Marri, A., Lachmi, B.-E., Olshevsky, U., Fremont, D. H., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01732-06 · Cited by 306
Self-citationWang, Q., Zhang, L., Kuwahara, K., Li, L., Liu, Z., Li, T., Zhu, H., Liu, J., Xu, Y., Xie, J., et al. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00006 · Cited by 304
Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus
Pastrana, D. V., Tolstov, Y. L., Becker, J. C., Moore, P. S., Chang, Y., & Buck, C. B. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000578 · Cited by 254
An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections
VanBlargan, L. A., Himansu, S., Foreman, B. M., Ebel, G. D., Pierson, T. C., & Diamond, M. S. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.082 · Cited by 123
“The infectious titer of RVPs was assayed using Raji-DC-SIGNR cells, as described previously (Ansarah-Sobrinho et al., 2008; Pierson et al., 2006).”
InfluentialSelf-citation
Metadata
- Authors
- Pierson, T. C., Sánchez, M. D., Puffer, B. A., Ahmed, A. A., Geiss, B. J., Valentine, L. E., Altamura, L. A., Diamond, M. S., & Doms, R. W.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 346
- Issue
- 1
- Pages
- 53-65
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2072890381
- Cited by
- 224
- References
- 1
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.